We found that targeted silencing of TACC3 markedly inhibited xenograft tumor growth and the formation of pulmonary metastatic nodes, suggesting that down-regulation of TACC3 suppresses EMT-induced invasion and metastasis. Here, TACC3 is linked to neoplasm.